# Met Non Small Cell Cancer Registry (MOMENT)

> **NCT05376891** · — · RECRUITING · sponsor: **EMD Serono Research & Development Institute, Inc.** · enrollment: 700 (estimated)

## Conditions studied

- Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05376891
- **Lead sponsor:** EMD Serono Research & Development Institute, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-10-04
- **Primary completion:** 2028-04-28
- **Final completion:** 2028-04-28
- **Target enrollment:** 700 (ESTIMATED)
- **Last updated:** 2026-05-08

## Collaborators

- Merck KGaA, Darmstadt, Germany

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05376891

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05376891, "Met Non Small Cell Cancer Registry (MOMENT)". Retrieved via AI Analytics 2026-08-08 from https://api.ai-analytics.org/clinical/NCT05376891. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*